Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Cell 2021 ; 184 (5): 1188-1200.e19 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection #MMPMID33577765
Brouwer PJM; Brinkkemper M; Maisonnasse P; Dereuddre-Bosquet N; Grobben M; Claireaux M; de Gast M; Marlin R; Chesnais V; Diry S; Allen JD; Watanabe Y; Giezen JM; Kerster G; Turner HL; van der Straten K; van der Linden CA; Aldon Y; Naninck T; Bontjer I; Burger JA; Poniman M; Mykytyn AZ; Okba NMA; Schermer EE; van Breemen MJ; Ravichandran R; Caniels TG; van Schooten J; Kahlaoui N; Contreras V; Lemaitre J; Chapon C; Fang RHT; Villaudy J; Sliepen K; van der Velden YU; Haagmans BL; de Bree GJ; Ginoux E; Ward AB; Crispin M; King NP; van der Werf S; van Gils MJ; Le Grand R; Sanders RW
Cell 2021[Mar]; 184 (5): 1188-1200.e19 PMID33577765show ga
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease. Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein. Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques. The vaccine-induced immunity protects macaques against a high-dose challenge, resulting in strongly reduced viral infection and replication in the upper and lower airways. These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.